FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288442933> ?p ?o ?g. }

• W4288442933 endingPage "F369" @default.
• W4288442933 startingPage "F361" @default.
• W4288442933 abstract "Loop diuretics are commonly used diuretics in the treatment of fluid retention but induce hypovolemia-related renal dysfunction. Na+-glucose cotransporter 2 (SGLT2) inhibitors induce osmotic diuresis, but body fluid volume is maintained by stimulating vasopressin-induced fluid intake and collecting duct water reabsorption as previously reported in diabetic rats. We aimed to test the hypothesis that unlike SGLT2 inhibitors, loop diuretics lack activation of similar fluid homeostatic mechanisms. Nondiabetic male Sprague-Dawley rats were treated daily by oral gavage with vehicle, the SGLT2 inhibitor ipragliflozin (5 mg/kg), or the loop diuretic furosemide (50 mg/kg) and monitored in metabolic cages for 2 or 7 days. Ipragliflozin and furosemide similarly increased urine volume on day 2. This was associated with increased serum Na+ concentration, urine vasopressin excretion, fluid intake, and solute-free water reabsorption in response to ipragliflozin but not to furosemide. Ipragliflozin maintained fluid balance (fluid intake - urine volume) on day 2 and total body water measured by bioimpedance spectroscopy and serum creatinine on day 7. In comparison, furosemide decreased fluid balance on day 2 and decreased total body water and increased serum creatinine on day 7. Furosemide, but not ipragliflozin, increased plasma renin activity, and systolic blood pressure was similar among the groups. In conclusion, the osmotic diuresis of the SGLT2 inhibitor increased serum Na+ concentration and the vasopressin-related stimulation of fluid intake and renal water retention maintained fluid balance, whereas the loop diuretic did not engage the compensatory vasopressin system. The data suggest differences in vasopressin and fluid homeostatic responses between SGLT2 inhibitors and loop diuretics.NEW & NOTEWORTHY In nondiabetic rats, the Na+-glucose cotransporter 2 (SGLT2) inhibitor ipragliflozin increased vasopressin-related stimulation of fluid intake and free water reabsorption and maintained fluid balance and serum creatinine, whereas the loop diuretic furosemide reduced vasopressin and induced a negative fluid balance followed by a subsequent increase in serum creatinine. This study suggests that differences in vasopressin secretion in response to a SGLT2 inhibitor or loop diuretic may contribute to differences in body fluid status and subsequent renal function." @default.
• W4288442933 created "2022-07-29" @default.
• W4288442933 creator A5061188627 @default.
• W4288442933 creator A5082904745 @default.
• W4288442933 creator A5085734264 @default.
• W4288442933 creator A5091003441 @default.
• W4288442933 date "2022-09-01" @default.
• W4288442933 modified "2023-10-03" @default.
• W4288442933 title "SGLT2 inhibitor and loop diuretic induce different vasopressin and fluid homeostatic responses in nondiabetic rats" @default.
• W4288442933 cites W1967706329 @default.
• W4288442933 cites W1968641755 @default.
• W4288442933 cites W1971180523 @default.
• W4288442933 cites W1984282395 @default.
• W4288442933 cites W2004221267 @default.
• W4288442933 cites W2017082665 @default.
• W4288442933 cites W2024514197 @default.
• W4288442933 cites W2048664109 @default.
• W4288442933 cites W2058874834 @default.
• W4288442933 cites W2074576032 @default.
• W4288442933 cites W2093568695 @default.
• W4288442933 cites W2095308161 @default.
• W4288442933 cites W2096294438 @default.
• W4288442933 cites W2127155176 @default.
• W4288442933 cites W2127611818 @default.
• W4288442933 cites W2141893784 @default.
• W4288442933 cites W2142561907 @default.
• W4288442933 cites W2214069701 @default.
• W4288442933 cites W2276559786 @default.
• W4288442933 cites W2298472009 @default.
• W4288442933 cites W2365143413 @default.
• W4288442933 cites W2418612502 @default.
• W4288442933 cites W2424539745 @default.
• W4288442933 cites W2745520514 @default.
• W4288442933 cites W2805527427 @default.
• W4288442933 cites W2807507993 @default.
• W4288442933 cites W2906340657 @default.
• W4288442933 cites W2907983377 @default.
• W4288442933 cites W2939222610 @default.
• W4288442933 cites W2944135920 @default.
• W4288442933 cites W2948220319 @default.
• W4288442933 cites W2966772964 @default.
• W4288442933 cites W2967001872 @default.
• W4288442933 cites W2974260792 @default.
• W4288442933 cites W3001352474 @default.
• W4288442933 cites W3004229541 @default.
• W4288442933 cites W3021951994 @default.
• W4288442933 cites W3036169394 @default.
• W4288442933 cites W3081830235 @default.
• W4288442933 cites W3088173406 @default.
• W4288442933 cites W3093167159 @default.
• W4288442933 cites W3104353694 @default.
• W4288442933 cites W3117862386 @default.
• W4288442933 cites W1568993432 @default.
• W4288442933 doi "https://doi.org/10.1152/ajprenal.00070.2022" @default.
• W4288442933 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35900341" @default.
• W4288442933 hasPublicationYear "2022" @default.
• W4288442933 type Work @default.
• W4288442933 citedByCount "8" @default.
• W4288442933 countsByYear W42884429332022 @default.
• W4288442933 countsByYear W42884429332023 @default.
• W4288442933 crossrefType "journal-article" @default.
• W4288442933 hasAuthorship W4288442933A5061188627 @default.
• W4288442933 hasAuthorship W4288442933A5082904745 @default.
• W4288442933 hasAuthorship W4288442933A5085734264 @default.
• W4288442933 hasAuthorship W4288442933A5091003441 @default.
• W4288442933 hasConcept C126322002 @default.
• W4288442933 hasConcept C134018914 @default.
• W4288442933 hasConcept C159641895 @default.
• W4288442933 hasConcept C185592680 @default.
• W4288442933 hasConcept C2776370428 @default.
• W4288442933 hasConcept C2776735168 @default.
• W4288442933 hasConcept C2777955127 @default.
• W4288442933 hasConcept C2778437025 @default.
• W4288442933 hasConcept C2779547328 @default.
• W4288442933 hasConcept C2779918671 @default.
• W4288442933 hasConcept C2780091579 @default.
• W4288442933 hasConcept C56906281 @default.
• W4288442933 hasConcept C63645605 @default.
• W4288442933 hasConcept C71924100 @default.
• W4288442933 hasConceptScore W4288442933C126322002 @default.
• W4288442933 hasConceptScore W4288442933C134018914 @default.
• W4288442933 hasConceptScore W4288442933C159641895 @default.
• W4288442933 hasConceptScore W4288442933C185592680 @default.
• W4288442933 hasConceptScore W4288442933C2776370428 @default.
• W4288442933 hasConceptScore W4288442933C2776735168 @default.
• W4288442933 hasConceptScore W4288442933C2777955127 @default.
• W4288442933 hasConceptScore W4288442933C2778437025 @default.
• W4288442933 hasConceptScore W4288442933C2779547328 @default.
• W4288442933 hasConceptScore W4288442933C2779918671 @default.
• W4288442933 hasConceptScore W4288442933C2780091579 @default.
• W4288442933 hasConceptScore W4288442933C56906281 @default.
• W4288442933 hasConceptScore W4288442933C63645605 @default.
• W4288442933 hasConceptScore W4288442933C71924100 @default.
• W4288442933 hasFunder F4320311436 @default.
• W4288442933 hasFunder F4320322299 @default.
• W4288442933 hasFunder F4320337337 @default.
• W4288442933 hasFunder F4320337338 @default.
• W4288442933 hasFunder F4320337357 @default.

• next